^
Association details:
Biomarker:No biomarker
Cancer:Sarcoma
Drug:Sutent (sunitinib) (c-KIT inhibitor, VEGFR inhibitor, PDGFR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Angiosarcoma: Other Recommended Regimens…Sunitinib